These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37332199)

  • 1. Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds.
    Melfi F; Carradori S; Angeli A; D'Agostino I
    Expert Opin Drug Discov; 2023; 18(8):851-879. PubMed ID: 37332199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors.
    Zarmouh NO; Messeha SS; Elshami FM; Soliman KF
    European J Med Plants; 2016 May; 15(1):. PubMed ID: 27341283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Bekircan O; Danış Ö; Şahin ME; Çetin M
    Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
    Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
    CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
    Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
    Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
    Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H
    Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 7,8-dihydroxy-3-phenylcoumarin as a reversible monoamine oxidase enzyme inhibitor.
    Musa MA; Badisa VLD; Aghimien MO; Eyunni SVK; Latinwo LM
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22651. PubMed ID: 33085988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors.
    Sudevan ST; Oh JM; Abdelgawad MA; Abourehab MAS; Rangarajan TM; Kumar S; Ahmad I; Patel H; Kim H; Mathew B
    Sci Rep; 2022 Dec; 12(1):22404. PubMed ID: 36575270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
    Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
    Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
    Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
    Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
    Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
    Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door.
    Mathew B; Carradori S; Guglielmi P; Uddin MS; Kim H
    Curr Med Chem; 2021; 28(2):266-283. PubMed ID: 31965939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-tert-Pentylphenoxyalkyl derivatives - Histamine H
    Łażewska D; Olejarz-Maciej A; Kaleta M; Bajda M; Siwek A; Karcz T; Doroz-Płonka A; Cichoń U; Kuder K; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3596-3600. PubMed ID: 30404719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.